# Gadolinium chloride anhydrous, 99\.9% — Safety Data Sheet — Glentham 原本PDFから抽出したテキストです。表、画像、記号、OCR結果は原本と異なる場合があります。安全情報は原本PDFで確認してください。 - **文書名:** Gadolinium chloride anhydrous, 99\.9% — Safety Data Sheet — Glentham - **発行元:** Glentham - **材料:** Gadolinium chloride anhydrous, 99\.9% - **CAS番号:** 10138\-52\-0 - **製品番号・グレード:** GX1913 - **文書種類:** SDS - **原文の言語:** English - **地域:** European Union · REACH / CLP - **改訂日:** 2023\-04\-05 - **ページ数:** 6 - **原本ファイル名:** 053\_Gadolinium\_chloride\_anhydrous\_99\_9\_Glentham\_EN\.pdf - **RESDSページ:** https://resds\.com/document/gadolinium\-chloride\-anhydrous\-99\-9\-sds\-en\-33f7bf5144 - **原本PDF:** https://resds\.com/pdf/gadolinium\-chloride\-anhydrous\-99\-9\-sds\-en\-33f7bf5144\.pdf - **情報源URL:** https://www\.glentham\.com/en/products/product/GX1913/sds/?language=en - **説明:** Original Glentham safety data sheet for Gadolinium chloride anhydrous, 99\.9%\. Original PDF retained without modification\. Source collected on 2026\-09\-13\. ## ページ 1 ```text GX1913 v3.0 Safety Data Sheet www.glentham.com According to REACH Regulations (EC) 1907/2006 and (EU) 2020/878 1. Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier Product code : GX1913 Product name : Gadolinium chloride anhydrous, 99.9% CAS number : 10138-52-0 Physical form : solid, substance REACH : A registration number is not available for this substance as the substance or its uses are exempted from registration, the annual tonnage does not require a registration or the registration is envisaged for a later registration deadline. 1.2 Relevant identified uses of the substance or mixture and uses advised against PC21: Laboratory chemicals. 1.3 Details of the supplier of the safety data sheet Company name : Glentham Life Sciences Ltd Telephone : +44 (0) 1225 667 798 Unit 5 Leafield Way Fax : +44 (0) 2033 978 909 Corsham SN13 9SW Email : info@glentham.com United Kingdom Web : www.glentham.com 1.4 Emergency telephone number Emergency telephone : NHS Direct 111 (UK, 24 hours), 112 (EU, 24 Hours), +44 (0) 1225 667 798 (09.00 – 17.00 GMT) number 2. Hazards identification 2.1 Classification of the substance or mixture Classification under CLP according to (EC) 1272/2008 H315 Skin Irr. 2 2.2 Label elements Label elements under CLP according to (EC) 1272/2008 Pictograms GHS07 Signal words Warning Hazard statements H315 Causes skin irritation Precautionary statements P280 Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 IF ON SKIN: wash with plenty of water. P332+P313 IF SKIN irritation occurs: Get medical advice/attention. P362 Take off contaminated clothing. P264 Do not breathe fume. 2.3 Other hazards PBT This substance is not identified as a PBT substance. 3.0 Composition/information on ingredients 3.1 Substances Page 1 of 6 Revision Date: 2023-04-05, Printed: 2024-06-07 20:43:16 ``` ## ページ 2 ```text GX1913 v3.0 Safety Data Sheet www.glentham.com Name Identifier % Classification Gadolinium chloride anhydrous, 99.9% CAS: 10138-52-0 99.9% H315, Skin Irr. 2 EC: REACH: Not applicable 4. First aid measures 4.1 Description of first aid measures Skin contact Consult a doctor. Drench the affected skin with running water for 10 minutes or longer if substance is still on skin. Remove all contaminated clothes and footwear immediately unless stuck to skin. Eye contact Consult a doctor. Bathe the eye with running water for 15 minutes. Ingestion Consult a doctor. Do not induce vomiting. If conscious, give half a litre of water to drink immediately. Wash out mouth with water. Inhalation Consult a doctor. Remove casualty from exposure ensuring one's own safety whilst doing so. 4.2 Most important symptoms and effects, both acute and delayed Skin contact There may be irritation and redness at the site of contact. Eye contact The eyes may water profusely. There may be pain and redness. Ingestion Nausea and stomach pain may occur. There may be difficulty swallowing. There may be soreness and redness of the mouth and throat. Inhalation Nausea and stomach pain may occur. There may be irritation of the throat with a feeling of tightness in the chest. Delayed / immediate Immediate effects can be expected after short-term exposure. Nausea and stomach pain may occur. effects 4.3 Indication of any immediate medical attention and special treatment needed Immediate / special treatment Do not induce vomiting. 5. Fire-fighting measures 5.1 Extinguishing media Suitable extinguishing media for the surrounding fire should be used. 5.2 Special hazards arising from the substance or mixture Exposure hazards In combustion emits toxic fumes. 5.3 Advice for fire-fighters Wear protective clothing to prevent contact with skin and eyes. Wear self-contained breathing apparatus. 6. Accidental release measures 6.1 Personal precautions, protective equipment and emergency procedures Personal precautions Mark out the contaminated area with signs and prevent access to unauthorised personnel. Refer to section 8 of SDS for personal protection details. 6.2 Environmental precautions Do not discharge into drains or rivers. 6.3 Methods and material for containment and cleaning up Clean-up procedures Transfer to a closable, labelled salvage container for disposal by an appropriate method. Page 2 of 6 Revision Date: 2023-04-05, Printed: 2024-06-07 20:43:16 ``` ## ページ 3 ```text GX1913 v3.0 Safety Data Sheet www.glentham.com 6.4 Reference to other sections Refer to section 8 of SDS. 7. Handling and storage 7.1 Precautions for safe handling Handling requirements Avoid direct contact with the substance. 7.2 Conditions for safe storage, including any incompatibilities Storage conditions Avoid contact with water or humidity. Keep container tightly closed. Store in cool, well ventilated area. 7.3 Specific end use(s) No data available. 8. Exposure controls/personal protection 8.1 Control parameters Workplace exposure limits No workplace exposure limit control parameters set 8.2 Exposure controls Engineering measures No data available. Respiratory protection Respiratory protective device with particle filter. Hand protection Protective gloves. Eye protection Ensure eye bath is to hand. Safety glasses. Skin protection Protective clothing. 9. Physical and chemical properties 9.1 Information on basic physical and chemical properties Physical state Solid Colour White Odour No data available. Melting point/Freezing point 609 °C Boiling point/initial boiling point/boiling range No data available. Flammability No data available. Lower/Upper explosion limit No data available. Flash Point No data available. Auto-ignition temperature No data available. Decomposition temperature No data available. pH No data available. Kinematic viscosity No data available. Solubility No data available. Partition coefficient n-octanol/water No data available. Vapour pressure No data available. Density/relative density No data available. Relative vapour pressure No data available. Particle characteristics No data available. 9.2 Other information No data available. 10. Stability and reactivity 10.1 Reactivity Stable under recommended transport or storage conditions. 10.2 Chemical stability Page 3 of 6 Revision Date: 2023-04-05, Printed: 2024-06-07 20:43:16 ``` ## ページ 4 ```text GX1913 v3.0 Safety Data Sheet www.glentham.com Stable under normal conditions. 10.3 Possibility of hazardous reactions Hazardous reactions Decomposition may occur on exposure to conditions or materials listed below. Hazardous reactions will not occur under normal transport or storage conditions. 10.4 Conditions to avoid Heat. 10.5 Incompatible materials Materials to avoid Strong acids. Strong oxidising agents. 11. Toxicological information 11.1 Information on toxicological effects a) Acute toxicity No data available. b) Skin corrosion/irritation Skin corrosion/irritation (Category 2) c) Serious eye damage/irritation No data available. d) Respiratory or skin sensitisation No data available. e) Germ cell mutagenicity No data available. f) Carcinogenicity No data available. g) Reproductive toxicity No data available. h) STOT-single exposure No data available. i) STOT-repeated exposure No data available. j) Aspiration hazard No data available. Symptoms / routes of exposure Skin contact There may be irritation and redness at the site of contact. Eye contact The eyes may water profusely. There may be pain and redness. Ingestion Nausea and stomach pain may occur. There may be difficulty swallowing. There may be soreness and redness of the mouth and throat. Inhalation Nausea and stomach pain may occur. There may be irritation of the throat with a feeling of tightness in the chest. Delayed / immediate Immediate effects can be expected after short-term exposure. Nausea and stomach pain may occur. effects Other information No data available. 11.2 Information on other hazards 11.2.1 Endocrine disrupting properties This product does not contain known or suspected endocrine disruptors according to REACH or relevant EU Regulations. 11.2.2 Other information Page 4 of 6 Revision Date: 2023-04-05, Printed: 2024-06-07 20:43:16 ``` ## ページ 5 ```text GX1913 v3.0 Safety Data Sheet www.glentham.com No additional information 12. Ecological information 12.1 Toxicity No data available. 12.2 Persistence and degradability Biodegradable. 12.3 Bioaccumulative potential No bioaccumulation potential. 12.4 Mobility in soil Readily absorbed into soil. 12.5 Results of PBT and vPvB assessment This substance is not identified as a PBT substance. 12.6 Endocrine disrupting properties This substance is not identified as having endocrine disrupting properties 12.7 Other adverse effects No data available. 13. Disposal considerations 13.1 Waste treatment methods Disposal operations Transfer to a suitable container and arrange for collection by specialised disposal company. NB The user's attention is drawn to the possible existence of regional or national regulations regarding disposal. 14. Transport information This product does not require a classification for transport. 15. Regulatory information 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture This Safety Data Sheet is prepared in accordance with Commission Regulation (EC) 1907/2006, amended by Commission Regulation (EU) 2020/878. Authorisations/Restrictions Regulation (EC) 1907/2006, REACH, Annex XIV list of substances subject to No data available. authorisation: Regulation (EC) 1907/2006, REACH, Annex XVII restrictions on the manufacture, placing No data available. on the market and use of certain dangerous substances: Regulation (EC) 1005/2009 on substances that deplete the ozone layer: No data available. Regulation (EC) 850/2004 on persistent organic pollutants, amended by (EU) No No data available. 2019/1021: 15.2 Chemical safety assessment A chemical safety assessment has not been carried out for the substance or the mixture by the supplier. 16. Other information H-Statement Full Texts H315 Causes skin irritation Abbreviations Full Texts Page 5 of 6 Revision Date: 2023-04-05, Printed: 2024-06-07 20:43:16 ``` ## ページ 6 ```text GX1913 v3.0 Safety Data Sheet www.glentham.com ADN European Agreement concerning the International Carriage of Dangerous Goods by Inland Waterways ADR European Agreement concerning the International Carriage of Dangerous Goods by Road ALARP As low as is reasonably practicable CAS Chemical Abstracts Service CLP Classification, Labelling and Packaging Regulations COSHH Control of Substances Hazardous to Health EC Number European Community Number EC50 Effective Concentration 50% EILINCS European List of Notified Chemical Substances EINECS European Inventory of Existing Commercial Chemical Substances GHS Globally Harmonised System HSE Health & Safety Executive UK IATA International Air Transport Association IM Intramuscular IMDG The International Maritime Dangerous Goods Code IP Intraperitoneal IV Intravascular LD50 Lethal Dose 50% LOEC Lowest Observable Effective Concentration LTEL Long Term Exposure Limit NOEC No Observable Effective Concentration OECD Organisation for Economic Cooperations and Development PBT Persistent Bioaccumulative Toxic PPE Personal Protective Equipment REACH Registration, Evaluation, Authorisation and Restriction of Chemicals RID Regulations Concerning the International Carriage of Dangerous Goods by Rail SC Subcutaneous SDS Safety Data Sheet STEL Short Term Exposure Limit STOT Specific Target Organ Toxicity VOC Volatile Organic Compounds vPvB Very Persistent and Very Bioaccumulative WEL Workplace Exposure Limits This Safety Data Sheet is prepared in accordance with Commission Regulation (EC) 1907/2006, amended by Commission Regulation (EU) 2020/878. Disclaimer: Glentham Life Sciences shall not be held liable for any damage resulting from handling or from contact with the above product. The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. This document does not guarantee the properties or quality of the product. Copyright © 2023 Glentham Life Sciences Limited. All rights reserved. Page 6 of 6 Revision Date: 2023-04-05, Printed: 2024-06-07 20:43:16 ```